# Efficacy and Tolerability of a Fractional Ablative Erbium Laser for Axillary Scarring for Hidradenitis Suppurativa Patients

> **NCT05470322** · NA · WITHDRAWN · sponsor: **Montefiore Medical Center**

## Conditions studied

- Hidradenitis Suppurativa
- Scarring

## Interventions

- **DEVICE:** Er: YAG laser

## Key facts

- **NCT ID:** NCT05470322
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-01
- **Primary completion:** 2027-07
- **Final completion:** 2027-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients were able to consented/enrolled into the study during the period of time the study was approved by the IRB. Study officially withdrawn with the IRB on 11/24/2025.
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05470322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05470322, "Efficacy and Tolerability of a Fractional Ablative Erbium Laser for Axillary Scarring for Hidradenitis Suppurativa Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05470322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*